Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.75)
# 1,744
Out of 5,170 analysts
309
Total ratings
58.33%
Success rate
-0.5%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMDA Omada Health | Maintains: Overweight | $32 → $30 | $14.11 | +112.62% | 2 | Mar 6, 2026 | |
| VEEV Veeva Systems | Maintains: Equal-Weight | $205 → $215 | $184.03 | +16.83% | 11 | Mar 5, 2026 | |
| HIMS Hims & Hers Health | Maintains: Equal-Weight | $40 → $21 | $23.15 | -9.29% | 5 | Feb 25, 2026 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $5 → $4 | $2.17 | +84.33% | 3 | Dec 18, 2025 | |
| AMWL American Well | Maintains: Equal-Weight | $11 → $6 | $5.59 | +7.33% | 6 | Dec 18, 2025 | |
| HCA HCA Healthcare | Downgrades: Underweight | $425 | $502.05 | -15.35% | 5 | Dec 15, 2025 | |
| ARDT Ardent Health | Downgrades: Equal-Weight | $22 → $12 | $9.03 | +32.89% | 3 | Nov 14, 2025 | |
| HNGE Hinge Health | Maintains: Overweight | $57 → $67 | $44.38 | +50.97% | 3 | Sep 23, 2025 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $157 → $144 | $205.73 | -30.01% | 15 | Aug 6, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $175 → $210 | $203.21 | +3.34% | 3 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $200 | $189.58 | +5.50% | 1 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $5 | $1.07 | +367.29% | 12 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $53.58 | +112.77% | 24 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $34.01 | +67.60% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $64.71 | +25.17% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $24.79 | +41.19% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $13.56 | +32.74% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $77.13 | +139.85% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $196.25 | -14.90% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $127.81 | -67.14% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $195.23 | -18.56% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $73.02 | +71.19% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $315.93 | -77.12% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $190.78 | +2.21% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $284.33 | +71.63% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $148.63 | +99.15% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $265.84 | +38.43% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $170.42 | +201.02% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $264.61 | +3.93% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $36.16 | +143.36% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $60.46 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $72.36 | +155.67% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $192.69 | +10.54% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $98.64 | -41.20% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $308.59 | -62.09% | 15 | Jun 16, 2020 |
Omada Health
Mar 6, 2026
Maintains: Overweight
Price Target: $32 → $30
Current: $14.11
Upside: +112.62%
Veeva Systems
Mar 5, 2026
Maintains: Equal-Weight
Price Target: $205 → $215
Current: $184.03
Upside: +16.83%
Hims & Hers Health
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $40 → $21
Current: $23.15
Upside: -9.29%
GoodRx Holdings
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $2.17
Upside: +84.33%
American Well
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $11 → $6
Current: $5.59
Upside: +7.33%
HCA Healthcare
Dec 15, 2025
Downgrades: Underweight
Price Target: $425
Current: $502.05
Upside: -15.35%
Ardent Health
Nov 14, 2025
Downgrades: Equal-Weight
Price Target: $22 → $12
Current: $9.03
Upside: +32.89%
Hinge Health
Sep 23, 2025
Maintains: Overweight
Price Target: $57 → $67
Current: $44.38
Upside: +50.97%
Silicon Laboratories
Aug 6, 2025
Maintains: Equal-Weight
Price Target: $157 → $144
Current: $205.73
Upside: -30.01%
Tenet Healthcare
Jun 9, 2025
Maintains: Overweight
Price Target: $175 → $210
Current: $203.21
Upside: +3.34%
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $189.58
Upside: +5.50%
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $1.07
Upside: +367.29%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $53.58
Upside: +112.77%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $34.01
Upside: +67.60%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $64.71
Upside: +25.17%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $24.79
Upside: +41.19%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $13.56
Upside: +32.74%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $77.13
Upside: +139.85%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $196.25
Upside: -14.90%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $127.81
Upside: -67.14%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $195.23
Upside: -18.56%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $73.02
Upside: +71.19%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $315.93
Upside: -77.12%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $190.78
Upside: +2.21%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $284.33
Upside: +71.63%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $148.63
Upside: +99.15%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $265.84
Upside: +38.43%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $170.42
Upside: +201.02%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $264.61
Upside: +3.93%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $36.16
Upside: +143.36%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $60.46
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $72.36
Upside: +155.67%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $192.69
Upside: +10.54%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $98.64
Upside: -41.20%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $308.59
Upside: -62.09%